BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 981987)

  • 41. Cannabis use and psychotic disorders: an update.
    Hall W; Degenhardt L; Teesson M
    Drug Alcohol Rev; 2004 Dec; 23(4):433-43. PubMed ID: 15763748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cannabis and psychosis].
    Curtis L; Rey-Bellet P; Merlo MC
    Rev Med Suisse; 2006 Sep; 2(79):2099-100, 2102-3. PubMed ID: 17073176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prodromal symptoms of schizophrenia].
    Elkhazen C; Chauchot F; Canceil O; Krebs MO; Baylé FJ
    Encephale; 2003; 29(6):469-77. PubMed ID: 15029081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of cannabis and stimulant disorders on diagnostic stability in psychosis.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    J Clin Psychiatry; 2014 Apr; 75(4):349-56. PubMed ID: 24813404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychiatric sequelae of phencyclidine abuse.
    Fauman B; Aldinger G; Fauman M; Rosen P
    Clin Toxicol; 1976; 9(4):529-38. PubMed ID: 10126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Relations of model and drug-induced psychoses to schizophrenic diseases].
    Hermle L; Spitzer M; Borchardt D; Gouzoulis E
    Fortschr Neurol Psychiatr; 1992 Oct; 60(10):383-92. PubMed ID: 1427555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Linking substance use with symptoms of subclinical psychosis in a community cohort over 30 years.
    Rössler W; Hengartner MP; Angst J; Ajdacic-Gross V
    Addiction; 2012 Jun; 107(6):1174-84. PubMed ID: 22151745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Does chronic psychosis due to amphetamines abuse exist? Study of 25 drug addicts].
    Charles-Nicolas AJ
    Nouv Presse Med; 1976 Nov; 5(37):2447-50. PubMed ID: 980758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Schizoid psychosis during cannabis intake (case report)].
    Gaszner P; Csernus I; Fülöp B; Gaszner G
    Neuropsychopharmacol Hung; 2004 Jun; 6(2):90-2. PubMed ID: 15787208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Depersonalization: a self-relations perspective.
    Frances A; Sacks M; Aronoff MS
    Int J Psychoanal; 1977; 58(3):325-31. PubMed ID: 892998
    [No Abstract]   [Full Text] [Related]  

  • 51. LSD psychosis or LSD-induced schizophrenia? A multimethod inquiry.
    Vardy MM; Kay SR
    Arch Gen Psychiatry; 1983 Aug; 40(8):877-83. PubMed ID: 6870484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review.
    Wilson L; Szigeti A; Kearney A; Clarke M
    Schizophr Res; 2018 Jul; 197():78-86. PubMed ID: 29117908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Psychotic illness during treatment with clomifen].
    Kapfhammer HP; Messer T; Hoff P
    Dtsch Med Wochenschr; 1990 Jun; 115(24):936-9. PubMed ID: 2357929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample.
    Kendler KS; Ohlsson H; Sundquist J; Sundquist K
    Am J Psychiatry; 2019 Sep; 176(9):711-719. PubMed ID: 31055966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Affective-cognitive structure and psychosis. New perspectives of the study of hallucination experience with psychodysleptics].
    Andreoli A
    Ann Med Psychol (Paris); 1976 Apr; 134(4):501-22. PubMed ID: 952433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Substance-induced psychoses: a critical review of the literature.
    Fiorentini A; Volonteri LS; Dragogna F; Rovera C; Maffini M; Mauri MC; Altamura CA
    Curr Drug Abuse Rev; 2011 Dec; 4(4):228-40. PubMed ID: 21999698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute psychosis induced by psychotomimetic drug abuse. I. Clinical findings.
    Bowers MB
    Arch Gen Psychiatry; 1972 Oct; 27(4):437-40. PubMed ID: 5072710
    [No Abstract]   [Full Text] [Related]  

  • 58. [The clinical course of chronic methamphetamine psychoses].
    Fujimori H; Nakatani Y; Sakaguchi M
    Fortschr Neurol Psychiatr; 1989 Sep; 57(9):383-94. PubMed ID: 2793033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. L-5-hydroxytryptophan for LSD-induced psychosis.
    Abraham HD
    Am J Psychiatry; 1983 Apr; 140(4):456-8. PubMed ID: 6601463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hallucinogen induced psychic disorders. Subjective experiences, psychopathology and differential diagnosis].
    Hermle L; Gouzoulis-Mayfrank E; Spitzer M
    Fortschr Neurol Psychiatr; 1996 Dec; 64(12):482-91. PubMed ID: 9053389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.